UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Bausch Health
BHC
$2.35B
| $4.12M | ﹤0.01% |
35,100
+200
| +0.6% | +$21.9K |
|
|
EQC
1002
DELISTED
Equity Commonwealth
EQC
| $4.1M | ﹤0.01% |
176,029
+11,000
| +7% | +$261K |
|
|
HBI
1003
DELISTED
Hanesbrands
HBI
| $4.1M | ﹤0.01% |
233,272
-65,280
| -22% | -$1.09M |
|
1004
Nu Skin
NUS
$253M
| $4.09M | ﹤0.01% |
29,625
-41,680
| -58% | -$4.91M |
|
|
CLC
1005
DELISTED
Clarcor
CLC
| $4.08M | ﹤0.01% |
63,454
-35
| -0.1% | -$2.08K |
|
1006
Graham Holdings Company
GHC
$5.14B
| $4.08M | ﹤0.01% |
10,180
+3,606
| +55% | +$1.4M |
|
1007
Reinsurance Group of America
RGA
$15.5B
| $4.07M | ﹤0.01% |
52,613
-200
| -0.4% | -$14.6K |
|
1008
MillerKnoll
MLKN
$1.63B
| $4.06M | ﹤0.01% |
137,698
-13,100
| -9% | -$392K |
|
|
PDM
1009
Piedmont Realty Trust
PDM
$1.21B
| $4.02M | ﹤0.01% |
243,209
-1,400
| -0.6% | -$24.2K |
|
1010
Equity Lifestyle Properties
ELS
$12.6B
| $4.01M | ﹤0.01% |
221,504
-3,200
| -1% | -$57.9K |
|
1011
Integer Holdings
ITGR
$4.25B
| $4M | ﹤0.01% |
99,063
-52,745
| -35% | -$1.86M |
|
1012
VanEck India Growth Leaders ETF
GLIN
$95M
| $3.99M | ﹤0.01% |
126,000
+91,400
| +264% | +$2.57M |
|
|
KBIO
1013
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $3.99M | ﹤0.01% |
112,757
+91,219
| +424% | +$3.06M |
|
1014
RLJ Lodging Trust
RLJ
$1.89B
| $3.98M | ﹤0.01% |
163,576
-100
| -0.1% | -$2.41K |
|
|
ENDP
1015
DELISTED
Endo International plc
ENDP
| $3.95M | ﹤0.01% |
58,531
-3,243
| -5% | -$185K |
|
|
FCE.A
1016
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $3.94M | ﹤0.01% |
206,463
+15,300
| +8% | +$298K |
|
1017
Texas Capital Bancshares
TCBI
$4.35B
| $3.93M | ﹤0.01% |
63,242
-19,843
| -24% | -$1.06M |
|
|
JAH
1018
DELISTED
JARDEN CORPORATION
JAH
| $3.93M | ﹤0.01% |
96,156
+2,250
| +2% | +$81.7K |
|
|
ATRS
1019
DELISTED
Antares Pharma, Inc.
ATRS
| $3.92M | ﹤0.01% |
874,296
-42,000
| -5% | -$171K |
|
|
GEVA
1020
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $3.92M | ﹤0.01% |
60,500
-2,700
| -4% | -$160K |
|
1021
Tetra Tech
TTEK
$8.78B
| $3.88M | ﹤0.01% |
693,490
-27,900
| -4% | -$151K |
|
|
IM
1022
DELISTED
Ingram Micro
IM
| $3.87M | ﹤0.01% |
164,868
-192,688
| -54% | -$4.52M |
|
|
HSH
1023
DELISTED
HILLSHIRE BRANDS CO
HSH
| $3.86M | ﹤0.01% |
115,496
+2,000
| +2% | +$64.9K |
|
1024
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
| $3.83M | ﹤0.01% |
132,285
+42,500
| +47% | +$1.23M |
|
1025
ON Semiconductor
ON
$18.3B
| $3.82M | ﹤0.01% |
463,167
-3,248
| -0.7% | -$23.7K |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.